These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5514572)

  • 21. The chemotherapy of rodent malaria. XIV. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 4. The response of normal and drug-resistant strains of Plasmodium berghei.
    Peters W
    Ann Trop Med Parasitol; 1971 Jun; 65(2):123-9. PubMed ID: 5090256
    [No Abstract]   [Full Text] [Related]  

  • 22. Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
    Ishii A; Sasa M; Chinzei H; Oshima S; Tanaka H
    Jpn J Exp Med; 1967 Aug; 37(4):301-21. PubMed ID: 5301401
    [No Abstract]   [Full Text] [Related]  

  • 23. The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei.
    Knight DJ; Williamson P
    Ann Trop Med Parasitol; 1982 Feb; 76(1):9-14. PubMed ID: 7044325
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of kelfizine associated with pyrimethamine on the diseases caused by Plasmodium berghei in the white mouse. Influence of high environmental temperatures].
    Aldighieri J; Dupoux R; Quilici M; Sautet J
    Bull Soc Pathol Exot Filiales; 1968; 61(5):765-8. PubMed ID: 5757295
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on Plasmodium berghei n. sp. Vincke and Lips, 1948. VI. Reaction of blood-induced infection in albino mice to daraprim 2:4-diamino pyrimidine.
    JASWANT SINGH ; KRISHNASWAMI AK; SATYA PRAKASH ; RAY AP; RAMAKRISHNAN SP
    Indian J Malariol; 1952 Jun; 6(2):183-8. PubMed ID: 13044279
    [No Abstract]   [Full Text] [Related]  

  • 26. The chemotherapy of rodent malaria. IX. Causal prophylaxis. I. A method for demonstrating drug action on exo-erythrocytic stages.
    Gregory KG; Peters W
    Ann Trop Med Parasitol; 1970 Mar; 64(1):15-24. PubMed ID: 5485706
    [No Abstract]   [Full Text] [Related]  

  • 27. Reciprocal cross resistance between cycloguanil hydrochloride and pyrimethamine in Plasmodium berghei infections in mice.
    Thompson PE; Bayles A
    J Parasitol; 1968 Jun; 54(3):588-93. PubMed ID: 5757732
    [No Abstract]   [Full Text] [Related]  

  • 28. Selection of strains of Plasmodium berghei resistant to quinine, chloroquine, and pyrimethamine.
    Jacobs RL
    J Parasitol; 1965 Jun; 51(3):481-2. PubMed ID: 5841340
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood schizontocidal activity of antibiotics against Plasmodium berghei sensitive as well as resistant to chloroquine, pyrimethamine and primaquine.
    Puri SK; Dutta GP
    Indian J Med Res; 1981 Jan; 73 Suppl():29-35. PubMed ID: 7026431
    [No Abstract]   [Full Text] [Related]  

  • 30. [Causal preventive activity of standard antimalarials in rodent malaria (Plasmodium berghei yoelii)].
    Fink E
    Z Tropenmed Parasitol; 1972 Mar; 23(1):35-48. PubMed ID: 5050530
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of the growth rate of the erythrocytic stages of Plasmodium berghei and comparisons of the potency of inocula after various treatments.
    Warhurst DC; Folwell RO
    Ann Trop Med Parasitol; 1968 Sep; 62(3):349-60. PubMed ID: 5714962
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic recombination in Plasmodium berghei.
    Walliker D; Carter R; Morgan S
    Parasitology; 1973 Apr; 66(2):309-20. PubMed ID: 4595115
    [No Abstract]   [Full Text] [Related]  

  • 33. Fansidar prophylaxis, therapy, and immune responses in rodent malaria (Plasmodium berghei).
    Ferraroni JJ; Speer CA
    J Parasitol; 1982 Aug; 68(4):609-15. PubMed ID: 6750070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficiency of pyrimethamine-sulphormethoxine in malaria suppression given as single weekly, fortnightly and monthly doses.
    Shafei AZ
    J Trop Med Hyg; 1975 Aug; 78(8):190-2. PubMed ID: 1107584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of cross-resistance between antifolate drugs in Plasmodium yoelii.
    Knowles G
    J Parasitol; 1982 Feb; 68(1):157-9. PubMed ID: 6210768
    [No Abstract]   [Full Text] [Related]  

  • 36. [Attempts to obtain a strain of Plasmodium berghei resistant to the kelfizine-pyrimethamine combination from a strain previously made resistant to sulfonamides].
    Dupoux R; Aldighieri J; Blancard A
    Bull Soc Pathol Exot Filiales; 1971; 64(2):214-9. PubMed ID: 5109304
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening of Morinda lucida leaf extract for antimalarial action on Plasmodium berghei berghei in mice.
    Makinde JM; Obih PO
    Afr J Med Med Sci; 1985; 14(1-2):59-63. PubMed ID: 2994441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of PABA and sulphadiazine on two pyrimethamine-resistant Plasmodium berghei yoelii lines.
    Morgan S
    Trans R Soc Trop Med Hyg; 1972; 66(4):542-3. PubMed ID: 5071069
    [No Abstract]   [Full Text] [Related]  

  • 39. Some studies on the effects of dihydrofolate reductase inhibitors.
    Gitteridge WE; Trigg PI
    Trans R Soc Trop Med Hyg; 1970; 64(1):12. PubMed ID: 5442030
    [No Abstract]   [Full Text] [Related]  

  • 40. The chemotherapy of rodent malaria. XI. Cyclically transmitted, chloroquine-resistant variants of the Keyberg 173 strain of Plasmodium berghei.
    Peters W; Bafort J; Ramkaran AE
    Ann Trop Med Parasitol; 1970 Mar; 64(1):41-51. PubMed ID: 5485709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.